Wells Fargo’s Oragenics OGEN Stock Holding History

Wells Fargo’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19	Hold	34	–	–	﹤0.01%	6816
2025 Q4	$27	Hold	34	–	–	﹤0.01%	6664
2025 Q3	$45	Hold	34	–	–	﹤0.01%	6512
2025 Q2	$130	Buy	+34	New	+$172	﹤0.01%	6462
2024 Q2	–	Sell	-1	Closed	-$36	–	7302
2024 Q1	$36	Hold	1	–	–	﹤0.01%	6928
2023 Q4	$119	Hold	1	–	–	﹤0.01%	6721
2023 Q3	$59	Hold	1	–	–	﹤0.01%	6882
2023 Q2	$50	Buy	+1	New	+$93	﹤0.01%	7055
2023 Q1	–	Hold	0	–	–	–	7131
2022 Q4	–	Hold	0	–	–	–	6842
2022 Q3	–	Hold	0	–	–	–	7160
2022 Q2	–	Hold	0	–	–	–	7291
2022 Q1	–	Hold	0	–	–	–	7599
2021 Q4	–	Hold	0	–	–	–	7636
2021 Q3	–	Hold	0	–	–	–	7352
2021 Q2	–	Hold	0	–	–	–	7279
2021 Q1	–	Hold	0	–	–	–	6747
2020 Q4	–	Hold	0	–	–	–	6846
2020 Q3	–	Hold	0	–	–	–	6720
2020 Q2	–	Hold	0	–	–	–	6655
2020 Q1	–	Hold	0	–	–	–	6610
2017 Q2	–	Sell	-5	Closed	-$41K	–	6387
2017 Q1	$41K	Buy	+5	New	+$53.9K	﹤0.01%	5515
2014 Q3	–	Hold	0	–	-$1K	–	6281
2014 Q2	–	Sell	-1	Closed	-$39.5K	–	6018
2014 Q1	$48K	Buy	+1	New	+$60.7K	﹤0.01%	4943
2013 Q3	–	Hold	0	–	-$8K	–	5788
2013 Q2	–	Hold	0	–	–	–	5116

Other funds holding OGEN

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

AAS

Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SJIM

St. Johns Investment Management Jacksonville, Florida $238M AUM 22.04% 1-Year Est. Return

Wells Fargo's OGEN Position: Q1 2026 in Review

Wells Fargo held its Oragenics (OGEN) position steady in Q1 2026 at 34 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #6816.

Wells Fargo first reported a position in OGEN in Q1 2014 and has held it in 10 quarters since. The position peaked at $48K in Q1 2014. 19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

Wells Fargo held 34 shares of Oragenics worth $19 as of Q1 2026.
Wells Fargo left its Oragenics share count unchanged in Q1 2026.
Oragenics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6816 holding.
Wells Fargo first reported a position in Oragenics in Q1 2014 and has held it in 10 quarters since.
Wells Fargo's Oragenics position peaked at $48K in Q1 2014.
19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.